The Trump administration is floating a proposal to establish a permanent framework for Medicare drug price negotiations. | ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal ...
CMS established a new national framework setting performance thresholds to qualify noninvasive, biomarker-based colorectal ...
When Medicare coverage for a drug, device, or other medical technology is conditioned on additional evidence development, several important policy questions arise: What will be the utility of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results